企業プロフィール
Vera Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- VERA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
31.63 USD (0.00%)
終値
最終更新: 2026年8月17日
2.24B USD
時価総額
株価変動の要因
As of Aug 17, 2026, VERA was little changed and closed at $31.63. No new same-company headline was identified in the current news window.
企業概要
Kidney-Disease Biologics
Vera Therapeutics develops therapies for immune-mediated kidney diseases. Its lead program targets B-cell survival signals implicated in abnormal antibody production.
Atacicept
Atacicept is a recombinant TACI fusion protein that binds BAFF and APRIL. It is under Priority Review for accelerated approval in adults with IgA nephropathy.
Commercial Transition
Vera is preparing to move from clinical development into a commercial-stage model centered on atacicept, subject to FDA approval.
今後のカタリスト
- FDA PDUFA target action date for atacicept on July 7, 2026.
- Potential U.S. launch of atacicept around mid-2026, subject to approval.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。